N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](2H31)hexadecanamide

Modify Date: 2024-03-04 19:13:48

N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](2H31)hexadecanamide structure	Common Name	N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](2H31)hexadecanamide
	CAS Number	852043-41-5	Molecular Weight	569.092
	Density	0.9±0.1 g/cm3	Boiling Point	675.4±55.0 °C at 760 mmHg
	Molecular Formula	C₃₄H₃₆D₃₁NO₃	Melting Point	N/A
	MSDS	N/A	Flash Point	362.3±31.5 °C

Use of N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](2H31)hexadecanamide

C16-Ceramide-d31 is deuterium labeled C16-Ceramide.

Name	N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](2H31)hexadecanamide
Synonym	More Synonyms

Description	C16-Ceramide-d31 is deuterium labeled C16-Ceramide.
Related Catalog	Research Areas >> Others
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

Density	0.9±0.1 g/cm3
Boiling Point	675.4±55.0 °C at 760 mmHg
Molecular Formula	C₃₄H₃₆D₃₁NO₃
Molecular Weight	569.092
Flash Point	362.3±31.5 °C
Exact Mass	568.706665
LogP	13.34
Vapour Pressure	0.0±4.7 mmHg at 25°C
Index of Refraction	1.480

Hexadecanamide-d, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-

N-[(2S,3R,4E)-1,3-Dihydroxy-4-octadecen-2-yl](H)hexadecanamide